Clinical trial
The Use of Anti-CD4 mAb-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis (an Open Proof of Concept Study)
NCT00372177 is registered in ClinicalTrials.gov with Biotectid GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Anti-CD4 mAb-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis (an Open Proof of Concept Study)
- Lead sponsor
- Biotectid GmbH
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- May 31, 2008
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune disease, inflammation, polyarthritis, rheumatism, rheumatoid arthritis